\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ gland\\ size\\ 2x\\ normal\\,\\ non\\ tender\\.\ \(0\)\
\-\ raiu\\:\\ \\ \\ \\ 4hr\\:\\ 42\\%\\ \\ \\ \\ \\ \\ 24hr\\:\\ \\ 58\\%\ \(0\)\
\-\ tft\\â\\€\\™s\\:\\ \\ ft4\\:\\ 2\\.58\\ \\ \\ \\ \\ tsh\\<0\\.08\ \(0\)\
\-\ treated\\ with\\ 15mci\\ i\\-123\\,\\ will\\ be\\ followed\\.\ \(0\)\
\-\ diffuse\\ symmetric\\ enlargement\\ of\\ the\\ thyroid\\ gland\\ with\\ increased\\ uptake\\.\\ \\ increased\\ target\\ to\\ background\\ ratio\\.\ \(0\)\
\-\ graves\\'\\ disease\ \(0\)\
\-\ grave\\'s\\ disease\ \(0\)\
\-\ slight\\ tremor\\,\\ no\\ other\\ symptoms\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ 4hr\\:\\ 0\\.11944663593244931\ \(0\)\
\-\ 2\\.58\\:\\ 0\\.11944663593244931\ \(0\)\
\-\ 15mci\\:\\ 0\\.11944663593244931\ \(0\)\
\-\ 2x\\:\\ 0\\.10925329504186188\ \(0\)\
\-\ tft\\:\\ 0\\.10925329504186188\ \(0\)\
\-\ gland\\:\\ 0\\.10704025562919614\ \(0\)\
\-\ 24hr\\:\\ 0\\.10329057286380063\ \(0\)\
\-\ \\:\\:\\ 0\\.09973013082270575\ \(0\)\
\-\ 0\\.08\\:\\ 0\\.09577843133783018\ \(0\)\
\-\ grave\\:\\ 0\\.0930972319732132\ \(0\)\
\-\ i\\-123\\:\\ 0\\.08981570915976894\ \(0\)\
\-\ tremor\\:\\ 0\\.08797507470456298\ \(0\)\
\-\ raiu\\:\\ 0\\.08633940360000085\ \(0\)\
\-\ ft4\\:\\ 0\\.08558509044724275\ \(0\)\
\-\ background\\:\\ 0\\.0823035676337985\ \(0\)\
\-\ graves\\:\\ 0\\.07867327237009958\ \(0\)\
\-\ target\\:\\ 0\\.07576407026230665\ \(0\)\
\-\ ratio\\:\\ 0\\.06967619088324674\ \(0\)\
\-\ 58\\:\\ 0\\.06942902737859409\ \(0\)\
\-\ tsh\\:\\ 0\\.06825192873633619\ \(0\)\
\-\ \\'\\:\\ 0\\.06379678837482781\ \(0\)\
\-\ 42\\:\\ 0\\.06363061844462292\ \(0\)\
\-\ increased\\:\\ 0\\.061484846523519286\ \(0\)\
\-\ slight\\:\\ 0\\.05911364527014348\ \(0\)\
\-\ \\%\\:\\ 0\\.058627089216059046\ \(0\)\
\-\ symmetric\\:\\ 0\\.05739505203280068\ \(0\)\
\-\ pe\\:\\ 0\\.05645271590508711\ \(0\)\
\-\ non\\:\\ 0\\.05194580434159573\ \(0\)\
\-\ thyroid\\:\\ 0\\.05150459477830457\ \(0\)\
\-\ tender\\:\\ 0\\.051006042547779844\ \(0\)\
\-\ uptake\\:\\ 0\\.049926226833738416\ \(0\)\
\-\ enlargement\\:\\ 0\\.04986130009536905\ \(0\)\
\-\ \\<\\:\\ 0\\.04850096363973221\ \(0\)\
\-\ size\\:\\ 0\\.04213052752027605\ \(0\)\
\-\ followed\\:\\ 0\\.04213052752027605\ \(0\)\
\-\ disease\\:\\ 0\\.04108051591810895\ \(0\)\
\-\ will\\:\\ 0\\.03931589732910503\ \(0\)\
\-\ diffuse\\:\\ 0\\.03804422677022522\ \(0\)\
\-\ treated\\:\\ 0\\.03761545347182146\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.037559216759491997\ \(0\)\
\-\ s\\:\\ 0\\.03604070098697922\ \(0\)\
\-\ symptoms\\:\\ 0\\.03131849230732558\ \(0\)\
\-\ other\\:\\ 0\\.028965272775036008\ \(0\)\
\-\ \\'s\\:\\ 0\\.027706567917162427\ \(0\)\
\-\ normal\\:\\ 0\\.019700183155869133\ \(0\)\
\-\ be\\:\\ 0\\.019378775343293075\ \(0\)\
\-\ no\\:\\ 0\\.0126535904515265\ \(0\)\
\-\ \\,\\:\\ 0\\.01194309112576268\ \(0\)\
\-\ to\\:\\ 0\\.00628041335945568\ \(0\)\
\-\ with\\:\\ 0\\.0034412992967614627\ \(0\)\
\-\ \\.\\:\\ 0\\.0020882080057262513\ \(0\)\
\-\ the\\:\\ 0\\.002033077716229791\ \(0\)\
\-\ of\\:\\ 0\\.0017132911882057121\ \(0\)\
